Model
Edge
Alnylam Pharmaceuticals, Inc.
0001438226
Filing Type
4
Filing Date
5/13/2026
Updated
5/14/26, 2:17 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership